HLSC-001

N/A

Report date: 2025/04/17 16:50:43

Base Information

Drug NameHLSC-001
Drug Alias NameHLSC-001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hepatogenic potential stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsUrea Cycle Disorders, Inborn
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEurope
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUnicyte SRL
China Registration ClassN/A

Develop Information

Active CompaniesUnicyte SRL
Inactive CompaniesN/A
Active IndicationsUrea Cycle Disorders, Inborn
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A